Cost-effectiveness of Direct Antiviral Agents for Hepatitis C Virus Infection and a Combined Intervention of Syringe Access and Medication-assisted Therapy for Opioid Use Disorders in an Injection Drug Use Population

Elizabeth R. Stevens, Kimberly A. Nucifora, Holly Hagan, Ashly E. Jordan, Jennifer Uyei, Bilal Khan, Kirk Dombrowski, Don C. Des Jarlais, R. Scott BraithwaiteClinical 2019 · DOI

Abstract

When considering health-sector costs alone, DAA alone was the most cost-effective intervention. However, with criminal justice system-related costs, DAA and MAT+ implemented together became the most cost-effective intervention.
BibTeX
@inproceedings{stevens2019cost,
  author = {Elizabeth R. Stevens and Kimberly A. Nucifora and Holly Hagan and Ashly E. Jordan and Jennifer Uyei and Bilal Khan and Kirk Dombrowski and Don C. Des Jarlais and R. Scott Braithwaite},
  title = {{Cost-effectiveness of Direct Antiviral Agents for Hepatitis C Virus Infection and a Combined Intervention of Syringe Access and Medication-assisted Therapy for Opioid Use Disorders in an Injection Drug Use Population}},
  booktitle = {Clinical},
  year = {2019},
  doi = {10.1093/cid/ciz726},
}

Loading related content...

Figure